Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

LeukoSite awarded SBIR grant for inflammatory bowel disease research

Sep. 6, 1996

Yamanouchi reveals 5HT3 agonist

Aug. 30, 1996

Provir effective in patients with travelers' diarrhea

Aug. 30, 1996

FDA approves Helidac for marketing

Aug. 30, 1996

Hepatitic C infection drug discovery alliance formed

Aug. 23, 1996

Tritec approved for U.S. market

Aug. 23, 1996

HemoCleanse, VivoRx to collaborate on bioartificial liver device

Aug. 16, 1996

Hepagene efficacy confirmed in phase III

Aug. 16, 1996

Zadaxin filing in Taiwan appears imminent

Aug. 16, 1996

BXT-51072 in phase I clinical trials

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...